Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
B68
Study information
Scientific title
Acronym
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Not Specified
Patient information sheet
Condition
Breast cancer
Intervention
Women whose primary treatment is complete and are recurrence free will be randomised to one of two groups:
1. Group A: Continued follow-up at a specialist clinic
2. Group B: Follow-up by their GP
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/01/1992
Overall trial end date
07/03/1994
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Previously diagnosed carcinoma of the breast stages I - III
2. Female
3. Primary treatment, including complications, completed at least 3 months ago.
Participant type
Patient
Age group
Not Specified
Gender
Female
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/01/1992
Recruitment end date
07/03/1994
Locations
Countries of recruitment
United Kingdom
Trial participating centre
UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom
Sponsor information
Organisation
Department of Health
Sponsor details
United Kingdom
Sponsor type
Not defined
Website
Funders
Funder type
Government
Funder name
UK Department of Health
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list